Will FDA OK Psilocybin Treatment in The Near Future?

Researchers at Johns Hopkins University School of Medicine recently reviewed existing research on the safety and abuse potential of psilocybin, the active compound in hallucinogenic (“magic”) mushrooms.

In their summary, published in the journal Neuropharmacology, they suggested that if psilocybin clears phase III clinical trials, the drug should be re-categorized from a schedule I drug (one with no known medical potential) to a schedule IV drug (accepted for medical use with lower...

[Read More ...]

source https://psychcentral.com/news/2018/10/01/will-fda-ok-psilocybin-treatment-in-the-near-future/139150.html